Phase IIIB-IV long term follow-up study for patients who participated in CAMMS03409

Update Il y a 4 ans
Reference: U1111-1148-2987

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate long-term safety of alemtuzumab


Inclusion criteria

  • Relapsing-Remitting Multiple Sclerosis